Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1901 clinical trials
featured
Myelofibrosis

Myelofibrosis

  • 532 views
  • 08 Nov, 2020
  • 1 location
featured
Hyperbaric Oxygen (HBO) Therapy for Traumatic Brain Injury

Hyperbaric Oxygen (HBO) Therapy for Traumatic Brain Injury

  • 3827 views
  • 25 Mar, 2021
  • 1 location
featured
Eltrombopag Added to Standard Immunosuppression in Treatment-Naive Severe Aplastic Anemia

Background: Severe aplastic anemia is a rare and serious blood disorder. It happens when the immune system starts to attack the bone marrow cells. This causes the bone marrow to stop making red blood cells, platelets, and white blood cells. Standard treatment for this disease is horse-ATG and cyclosporine, which …

myelodysplastic syndrome (mds)
aplastic anemia
anemia studies
myelodysplastic syndromes
anemia
  • 123 views
  • 22 Dec, 2020
  • 1 location
IMG-7289 in Patients With Essential Thrombocythemia

This is a Phase 2b open label study of an orally administered LSD1 inhibitor, IMG-7289, in patients with essential thrombocythemia. This study investigates the following:

thrombosis
interferon
thrombocytosis
platelet count
  • 1 views
  • 31 Jul, 2021
  • 6 locations
Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

treatment as second-line therapy for subjects with ET who have had a suboptimal or failed response to HU.

anagrelide
thrombocytosis
hydroxyurea
interferon
neutrophil count
  • 0 views
  • 20 Mar, 2021
  • 51 locations
Adj. Dyn. Marker-adjusted Personalized Therapy Comparing Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk HR+/HER2- EBC

, will be eligible for the study. This patient group is currently offered a standard of care chemotherapy plus endocrine therapy (ET). The study investigates whether the patient group with high-risk

  • 0 views
  • 03 Sep, 2021
  • 9 locations
Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk HR+/HER2- EBC

The study investigates, whether the patient group with intermediate-risk early breast cancer benefits from treatment with ribociclib in combination with endocrine therapy compared to standard-of-care chemotherapy (followed by adjuvant endocrine therapy).

toremifene
endocrine therapy
hormone therapy
luminal
HER2
  • 0 views
  • 24 Jan, 2021
  • 8 locations
Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET

The purpose of this study is to investigate whether oral Gushen Antai pills supplementation for luteal phase support will improve ongoing pregnancy rate in women with normal ovarian reserve in fresh embryo transfer cycles.

  • 0 views
  • 10 Aug, 2021
  • 1 location
Regimens Comparison for Breast Cancers of Positive Lymph Nodes

To compare the efficacy and safety of EC-T and ET regimen as adjuvant treatment of breast cancer patients with positive lymph nodes

epirubicin
immunostimulant
paclitaxel
cancer surgery
  • 6 views
  • 08 Nov, 2020
  • 1 location
Anatomical Radiological and Biomechanical Examination of Athletic Groin Pain Patients and Physical Therapy Intervention

Athletic groin pain (AGP) is a chronic condition common in multi-directional sports (Walden et al. 2007, Robinson et al. 2004, Murphy et al. 2012). It is a complex injury with a challenging

  • 0 views
  • 21 Jan, 2021
  • 1 location